Global health visionary will be sorely missed.
MMV adds its voice to the many in the global health community, honouring the life of Dr Tachi Yamada who passed away on August 4, 2021.
MMV is reminded of his work each time we describe our business model as a Product Development Partnership (PDP), as it was Dr Yamada’s vision while at the Bill and Melinda Gates Foundation (BMGF) that not only branded PDPs—not for profit developers of health products for the underserved around the world—but that supported the creation and growth of this not-for-profit sector of the pharmaceutical industry.
When he transitioned out from the BMGF and back into the pharmaceutical industry, he worked to establish ways in which the Japanese industry and government could join with the PDPs and others to help ease the burden of severe disease in low- and middle-income countries, by envisioning and helping to create the Global Health Investment Technology Fund, a key donor for PDPs.
“His vision and support helped lead MMV and its partners to create 11 products, and our sister organizations to create many more in areas such as tuberculosis and neglected diseases,” said David Reddy, CEO of MMV. “His lifelong ability to connect people and ideas, to reach across cultural and country barriers, through many establishments from hospitals to foundations to industries to governments gave the global health community a model for how we can think and behave to create equity and reach for all.”
MMV extends sincere condolences to Dr Yamada’s family, friends and colleagues.